Literature DB >> 29288368

Single nucleotide polymorphism of Methyl-CpG-binding protein 2 gene associates with juvenile idiopathic arthritis.

Mahdi Mahmoudi1, Elham Hamzeh1, Saeed Aslani1, Vahid Ziaee2,3, Shiva Poursani1, Nima Rezaei4,5,6.   

Abstract

Methyl-CpG-binding protein 2 (MeCP2) is a transcription suppressor or activator, acting through binding to methylated DNA. Numerous investigations have established a role for methylation aberrancies in the pathogenesis of autoimmune disorders. Single nucleotide polymorphisms (SNPs) in MECP2 gene have been implicated with susceptibility to rheumatoid arthritis (RA). Here, the plausible association of MECP2 gene polymorphisms was evaluated with juvenile idiopathic arthritis (JIA) predisposition in Iranian pediatric patients. In this case-control association study, 49 JIA patients and 398 age-, sex-, and ethnicity-matched healthy individuals were included. Genotyping of all samples for MECP2 gene rs1734787, rs1734791, rs1734792, and rs17435 polymorphisms was conducted by real-time allelic discrimination PCR technique. Except the AT genotype of rs17435 SNP, none of the alleles and genotypes of other positions were distributed significantly between JIA cases and controls. AT genotype was less frequent in JIA cases and was found to be protective genotype of JIA proneness (OR = 0.42; CI, 0.19-0.90; P = 0.028). Among the haplotypes, CCAA and TTTT were detected to have significant difference between cases and controls (OR = 1.74; CI, 1.01-2.98; P = 0.042 and OR = 1.82; CI, 1.05-3.13; P = 0.028). All positions were in linkage disequilibrium with each other according to D'. MECP2 gene rs17435 polymorphism was associated with JIA predisposition. Considering the involvement of genetic polymorphisms of MECP2 gene in susceptibility to adult-onset RA, this gene might basically play a role in the initiation of arthritis during early stages of life.

Entities:  

Keywords:  Arthritis; JIA; MECP2; Methylation; SNP

Mesh:

Substances:

Year:  2017        PMID: 29288368     DOI: 10.1007/s10067-017-3968-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  45 in total

Review 1.  Juvenile arthritis: current concepts in terminology, etiopathogenesis, diagnosis, and management.

Authors:  S Abramowicz; S Kim; S Prahalad; A F Chouinard; L B Kaban
Journal:  Int J Oral Maxillofac Surg       Date:  2016-05-06       Impact factor: 2.789

2.  Variants in IRAK1-MECP2 region confer susceptibility to autoimmune thyroid diseases.

Authors:  Rong-hua Song; Qiu Qin; Ni Yan; Fatuma-said Muhali; Shuai Meng; Shuang-tao He; Jin-an Zhang
Journal:  Mol Cell Endocrinol       Date:  2014-10-18       Impact factor: 4.102

Review 3.  Juvenile arthritis--who gets it, where and when? A review of current data on incidence and prevalence.

Authors:  B Andersson Gäre
Journal:  Clin Exp Rheumatol       Date:  1999 May-Jun       Impact factor: 4.473

4.  Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients.

Authors:  J Karami; M Mahmoudi; A Amirzargar; M Gharshasbi; A Jamshidi; S Aslani; M H Nicknam
Journal:  Genes Immun       Date:  2017-08-10       Impact factor: 2.676

5.  Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis.

Authors:  Vahid Ziaee; Arezou Rezaei; Sara Harsini; Marzieh Maddah; Samaneh Zoghi; Maryam Sadr; Mohammad Hassan Moradinejad; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2016-03-07       Impact factor: 2.980

Review 6.  MeCP2: multifaceted roles in gene regulation and neural development.

Authors:  Tian-Lin Cheng; Zilong Qiu
Journal:  Neurosci Bull       Date:  2014-08-01       Impact factor: 5.203

7.  Genetic association between juvenile rheumatoid arthritis and polymorphism in the SH2D2A gene.

Authors:  A Smerdel; K-Z Dai; A R Lorentzen; B Flatø; S Maslinski; E Thorsby; Ø Førre; A Spurkland
Journal:  Genes Immun       Date:  2004-06       Impact factor: 2.676

8.  Emerging patterns of genetic overlap across autoimmune disorders.

Authors:  Corinne Richard-Miceli; Lindsey A Criswell
Journal:  Genome Med       Date:  2012-01-27       Impact factor: 11.117

9.  Common variants within MECP2 confer risk of systemic lupus erythematosus.

Authors:  Amr H Sawalha; Ryan Webb; Shizhong Han; Jennifer A Kelly; Kenneth M Kaufman; Robert P Kimberly; Marta E Alarcón-Riquelme; Judith A James; Timothy J Vyse; Gary S Gilkeson; Chan-Bum Choi; R Hal Scofield; Sang-Cheol Bae; Swapan K Nath; John B Harley
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

10.  Variants in CXCR4 associate with juvenile idiopathic arthritis susceptibility.

Authors:  Terri H Finkel; Jin Li; Zhi Wei; Wei Wang; Haitao Zhang; Edward M Behrens; Emma L Reuschel; Sophie Limou; Carol Wise; Marilynn Punaro; Mara L Becker; Jane E Munro; Berit Flatø; Øystein Førre; Susan D Thompson; Carl D Langefeld; David N Glass; Joseph T Glessner; Cecilia E Kim; Edward Frackelton; Debra K Shivers; Kelly A Thomas; Rosetta M Chiavacci; Cuiping Hou; Kexiang Xu; James Snyder; Haijun Qiu; Frank Mentch; Kai Wang; Cheryl A Winkler; Benedicte A Lie; Justine A Ellis; Hakon Hakonarson
Journal:  BMC Med Genet       Date:  2016-03-22       Impact factor: 2.103

View more
  1 in total

Review 1.  DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis.

Authors:  Marzena Ciechomska; Leszek Roszkowski; Wlodzimierz Maslinski
Journal:  Cells       Date:  2019-08-22       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.